What the Iran War Means for Pharma Supply Chains
Argon & Co’s Michel Savini discusses the medicines most exposed to geopolitical instability, and why scenario planning remains underused across life sciences
Clinical Scorecard: What the Iran War Means for Pharma Supply Chains
At a Glance
Category Detail
Condition Pharmaceutical Supply Chain Disruption Key Mechanisms Geopolitical instability affecting APIs, cold chain logistics, manufacturing costs, and access to critical medicines. Target Population Life sciences companies and patients relying on pharmaceuticals. Care Setting Pharmaceutical manufacturing and distribution.
Key Highlights
Only 22% of firms are preparing for supply chain disruptions. 62% of life sciences leaders report pressure to reduce operational costs. Medicines requiring refrigeration are particularly vulnerable to geopolitical instability. Energy market disruptions are impacting pharmaceutical manufacturing costs. Scenario planning is underused in the pharmaceutical industry. Guideline-Based Recommendations
Diagnosis
Identify vulnerabilities in supply chains related to geopolitical risks. Management
Implement dual sourcing and increased safety stock for critical medicines. Monitoring & Follow-up
Continuously assess geopolitical risks and their impact on supply chains. Risks
Potential for widespread medicine shortages and increased prices due to supply chain disruptions. Patient & Prescribing Data
Patients dependent on essential medicines, particularly those requiring refrigeration.
Rising costs and potential shortages may affect access to medications.
Clinical Best Practices
Adopt a strategic approach to supply chain design based on product criticality. Integrate scenario planning into everyday decision-making. Balance efficiency with resilience in supply chain management. Related Resources & Content
